As of 2025-09-18, the EV/EBITDA ratio of Ramm Pharma Corp (RAMM.CN) is -0.10. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. RAMM.CN's latest enterprise value is 0.49 mil CAD. RAMM.CN's TTM EBITDA according to its financial statements is -5.04 mil CAD. Dividing these 2 quantities gives us the above RAMM.CN EV/EBITDA ratio.
Note: valuation result may not be accurate due to the company's negative EBITDA.
| Range | Selected | |
| Trailing P/E multiples | 2.2x - 5.3x | 3.4x |
| Forward P/E multiples | 0.6x - 1.5x | 0.7x |
| Fair Price | (0.09) - (0.06) | (0.08) |
| Upside | -970.6% - -674.9% | -907.3% |
| Date | EV/EBITDA |
| 2025-09-12 | -0.10 |
| 2025-09-04 | -0.10 |
| 2025-09-03 | -0.22 |
| 2025-09-02 | -0.22 |
| 2025-08-01 | -0.10 |
| 2025-07-30 | -0.10 |
| 2025-07-25 | -0.10 |
| 2025-07-24 | -0.22 |
| 2025-07-16 | -0.10 |
| 2025-07-07 | -0.10 |
| 2025-06-27 | -0.10 |